Angiotensin-I-converting enzyme inhibitory peptides in milk fermented by indigenous lactic acid bacteria

被引:38
作者
Rubak, Yuliana Tandi [1 ]
Nuraida, Lilis [1 ,2 ]
Iswantini, Dyah [3 ,4 ]
Prangdimurti, Endang [1 ]
机构
[1] IPB Univ, Bogor Agr Univ, Food Sci Study Program, Dept Food Sci & Technol, Bogor, Indonesia
[2] IPB Univ, Bogor Agr Univ, Southeast Asian Food & Agr Sci & Technol Ctr, Bogor, Indonesia
[3] IPB Univ, Bogor Agr Univ, Dept Chem, Bogor, Indonesia
[4] IPB Univ, Bogor Agr Univ, Trop Biopharmaca Res Ctr, Bogor, Indonesia
关键词
angiotensin-I-converting enzyme inhibitory peptides; fermented milk; indigenous lactic acid bacteria; Lactobacillus kefiri; BIOACTIVE PEPTIDES; ANTIHYPERTENSIVE PEPTIDES; BOVINE-MILK; IDENTIFICATION; CASEIN; ANTIOXIDANT; FOOD; PURIFICATION; DIPEPTIDES; PROTEINASE;
D O I
10.14202/vetworld.2020.345-353
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Background and Aim: Fermented milk can be used to produce antihypertensive peptides. Lactic acid bacteria (LAB) with its proteolytic system hydrolyze milk protein during fermentation to produce several peptides, which include antihypertensive bioactive peptides. This study aimed to investigate the ability of indigenous LAB for the production of angiotensin-I-converting enzyme inhibitory (ACE-I) peptides in fermented milk and to characterize the ACEI peptides. Materials and Methods: Reconstituted milk (11%) inoculated with ten LAB isolates, and then incubated at 37 degrees C until it reaches pH 4.6. The evaluation was carried out for LAB count, lactic acid concentration, peptide content, and ACE-I activity. The low molecular weight (MW) peptides (<3 kDa) were identified using Nano LC Ultimate 3000 series system Tandem Q Exactive Plus Oibitrap high-resolution mass spectrometry. Results: The result showed that the ten LAB isolates were able to produce ACE-I in fermented milk with the activities in the range of 22.78 +/- 2.55-57.36 +/- 5.40%. The activity of ACE-I above 50% produced by Lactobacillus delbrueckii BD7, Lactococcus lactis ssp. lactis BD17, and Lactobacillus kefiri YK4 and JK17. with the highest activity of ACE-I produced by L. kefiri YK4 (IC50 0.261 mg/mL) and L. kefiri JK17 (IC50 0.308 mg/mL). Results of peptide identification showed that L. kefiri YK 4 could release as many as 1329, while L. kefiri JK 17 could release 174 peptides. The peptides produced were 95% derived from casein. The other peptides were from alpha-lactalbumin, beta-lactoglobulin, and serum amyloid A. The peptides produced consisted of 6-19 amino acid residues, with MWs of 634-2079 Dalton and detected at 317-1093 m/z. A total of 30 peptides have been recognized based on literature searches as ACE-I peptides (sequence similarity: 100%). Conclusion: L. kefiri YK4 and JK17 are the potential to be used as starter cultures to produce the bioactive peptide as ACE-I in fermented milk.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 50 条
[41]   Purification and Production of Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Bioactive Peptides Derived from Fermented Goat Milk [J].
Parmar, Heena ;
Hati, Subrota ;
Panchal, Gauravkumar ;
Sakure, Amar A. .
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (02) :997-1011
[42]   Angiotensin converting enzyme and nitric oxide inhibitory activities of novel milk derived peptides [J].
Phelan, Martha ;
Khaldi, Nora ;
Shields, Denis C. ;
Kerins, David M. .
INTERNATIONAL DAIRY JOURNAL, 2014, 35 (01) :38-42
[43]   Plant Food-Derived Angiotensin I Converting Enzyme Inhibitory Peptides [J].
Guang, Cuie ;
Phillips, Robert D. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (12) :5113-5120
[44]   Bioavailability of angiotensin I converting enzyme inhibitory peptides [J].
Vermeirssen, V ;
Van Camp, J ;
Verstraete, W .
BRITISH JOURNAL OF NUTRITION, 2004, 92 (03) :357-366
[45]   Characterization of angiotensin-converting enzyme inhibitory activity of fermented milk produced by Lactobacillus helveticus [J].
Chen, Yongfu ;
Li, Changkun ;
Xue, Jiangang ;
Kwok, Lai-yu ;
Yang, Jie ;
Zhang, Heping ;
Menghe, Bilige .
JOURNAL OF DAIRY SCIENCE, 2015, 98 (08) :5113-5124
[46]   Novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides released from quinoa protein by in silico proteolysis [J].
Guo, Huimin ;
Richel, Aurore ;
Hao, Yuqiong ;
Fan, Xin ;
Everaert, Nadia ;
Yang, Xiushi ;
Ren, Guixing .
FOOD SCIENCE & NUTRITION, 2020, 8 (03) :1415-1422
[47]   In silico approaches towards the exploration of rice bran proteins-derived angiotensin-I-converting enzyme inhibitory peptides [J].
Pooja, Km ;
Rani, Sapna ;
Prakash, Bhanu .
INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2017, 20 :2178-2191
[48]   In Silico and In vitro Analysis of Novel Angiotensin I-Converting Enzyme (ACE) inhibitory Bioactive Peptides Derived from Fermented Camel Milk (Camelus dromedarius) [J].
Solanki, Divyangkumar ;
Hati, Subrota ;
Sakure, Amar .
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2017, 23 (04) :441-459
[49]   Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP [J].
Gregory, Kyle S. ;
Cozier, Gyles E. ;
Schwager, Sylva L. U. ;
Sturrock, Edward D. ;
Acharya, K. Ravi .
FEBS LETTERS, 2024, 598 (02) :242-251
[50]   Isolation and evaluation of two angiotensin-I- converting enzyme inhibitory peptides from fermented grains (Jiupei) used in Chinese Baijiu production [J].
Zhang, Limo ;
Jiang, Yunsong ;
Yin, Zhongtian ;
Sun, Jinyuan ;
Li, Hehe ;
Sun, Xiaotao ;
Huang, Mingquan ;
Zheng, Fuping .
RSC ADVANCES, 2018, 8 (65) :37451-37461